Ataluren, a new therapeutic for alpha-1 antitrypsin deficient individuals with nonsense mutations
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
American Thoracic Society
2018
|
Main Authors: | , , , , , , , , , |
---|---|
Format: | Journal article |
Published: |
American Thoracic Society
2018
|